封面
市场调查报告书
商品编码
1490024

预防性医疗技术和服务的全球市场:按服务类型、按技术类型、按最终用户、按地区

Global Preventive Healthcare Technologies And Services Market, By Service Type, By Technology Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年,全球预防保健技术和服务市场价值将达到2,752.9亿美元,预计2031年将达到5,566.4亿美元,2024年至2031年复合年增长率为10.6%。

报告范围 报告详情
基准年 2023年 2024年市场规模 2752.9亿美元
实际资料 2019-2023 预测期 2024-2031
预测期:2024-2031年复合年增长率: 10.60% 2031 年金额预测 5566.4亿美元
图:2024 年按地区分類的预防性医疗技术和服务的全球市场占有率(%)
全球预防保健技术与服务市场-IMG1

近年来,全球预防保健技术和服务市场经历了显着成长。预防性医疗保健旨在预防疾病、病症和伤害并促进身体健康。科技的进步和对人口健康管理日益浓厚的兴趣正在扩大预防医学的范围。诊断影像、先进生物标记和遗传学等各种技术使得早期发现疾病和评估风险成为可能。此外,数位健康解决方案的普及支持远端监控并促进获得预防服务。随着世界各地慢性病的盛行率增加,对预防干预措施的需求呈指数级增长。这促使投资开发创新的预防性医疗保健模式和干预措施。随着人们对预防的日益重视,预计该市场在未来几年将显着成长。

市场动态:

与文明病盛行率不断上升,越来越多的老年人更容易患上慢性病,以及与治疗相关的医疗费用的增加,正在推动对预防性医疗技术和服务的需求。针对公共卫生的各种政府计划也在推动这些解决方案的采用。然而,先进预防医疗技术和服务的部署因所需的大量投资而受到阻碍。开拓负担得起的预防解决方案对于市场开拓来说是一个机会。整合人工智慧等最尖端科技也有可能彻底改变预防性医疗保健。

本研究的主要特点

  • 该报告对全球预防保健技术和服务市场进行了详细分析,并列出了以2023年为基准年的预测期(2024-2031年)的市场规模和年复合成长率(CAGR%)。
  • 它还强调了各个细分市场的潜在收益成长机会,并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 根据公司亮点、产品系列、主要亮点、绩效和策略等参数,提供全球预防保健技术和服务市场中主要企业的概况。
  • 主要企业包括Healthlane、Abbott、GSK plc、Myriad Genetics、Omron Healthcare Inc.、Quest Diagnostics、Pfizer, Inc.、Merck &Co., Inc.、Omnicell、Novx Systems, Corp.、U-Systems, Ltd.。 Viatronix , Inc.、Scripto LLC、Lifecom, Inc.、Dilon Medical Technologies, Inc. 和 McKesson Corporation。
  • 从这份报告中获得的见解将使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球预防保健技术和服务市场迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 透过用于分析全球预防保健技术和服务市场的各种策略矩阵,将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 收购和合作场景
  • 产品发布/核准
  • 品牌及价格分析
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球预防性医疗保健技术与服务市场-冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球预防保健技术与服务市场,依服务类型,2019-2031

  • 诊断服务
  • 健康/健康评估服务
  • 远端医疗服务
  • 药局服务
  • 其他的

第六章全球预防保健技术与服务市场,依技术类型,2019-2031

  • 远端医疗
  • 行动医疗
  • 医疗资讯技术
  • 穿戴式装置
  • 其他的

第 7 章 全球预防保健技术与服务市场,依最终使用者划分,2019-2031 年

  • 医疗服务提供方
  • 医疗保健付款人
  • 其他的

第八章全球预防医疗技术和服务市场,按地区,2019-2031

第9章 竞争格局

  • 公司简介
    • Healthlane
    • Abbott
    • GSK plc
    • Myriad Genetics
    • Omron Healthcare Inc.
    • Quest Diagnostics
    • Pfizer, Inc.
    • Merck &Co., Inc.
    • Omnicell
    • Novx Systems, Corp.
    • U-Systems, Ltd.
    • Viatronix, Inc.
    • Scripto LLC
    • Lifecom, Inc.
    • Dilon Medical Technologies, Inc.
    • McKesson Corporation

第10章分析师的观点

  • 命运之轮
  • 分析师观点
  • Coherent Opportunity Map

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI6961

The global preventive healthcare technologies and services market is estimated to be valued at USD 275.29 Bn in 2024 and is expected to reach USD 556.64 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 275.29 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 10.60% 2031 Value Projection: US$ 556.64 Bn
Figure. Global Preventive Healthcare Technologies And Services Market Share (%), By Region 2024
Global Preventive Healthcare Technologies And Services Market - IMG1

The global preventive healthcare technologies and services market has been witnessing significant growth in recent years. Preventive healthcare aims to prevent diseases, conditions or injuries and promote good health. Advancements in technologies and growing focus on population health management have expanded the scope of preventive care. Various technologies such as imaging, advanced biomarkers, and genetics have enabled early detection and risk assessment of diseases. In addition, the widespread adoption of digital health solutions is supporting remote monitoring and facilitating access to preventive services. As the prevalence of chronic diseases rises worldwide, the demand for preventive interventions is growing exponentially. This has prompted investments into the development of innovative preventive healthcare models and measures. The market is expected to grow substantially in the coming years as focus on prevention gains more prominence.

Market Dynamics:

Rising incidence of lifestyle diseases, growing geriatric population susceptible to chronic illnesses and increasing healthcare costs associated with treatment are driving the demand for preventive healthcare technologies and services. Various government programmes aimed at population health are also boosting the adoption of these solutions. However, high investment requirements for the deployment of advanced preventive technologies and services act as a restraint. Developing affordable preventive solutions represents an opportunity for market players. Integrating cutting-edge technologies, such as artificial intelligence, also holds potential to revolutionize preventive care.

Key Features of the Study:

  • This report provides an in-depth analysis of the global preventive healthcare technologies and services market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global preventive healthcare technologies and services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Healthlane, Abbott , GSK plc, Myriad Genetics, Omron Healthcare Inc., Quest Diagnostics, Pfizer, Inc., Merck & Co., Inc., Omnicell , Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., Scripto LLC , Lifecom, Inc., Dilon Medical Technologies, Inc., and McKesson Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global preventive healthcare technologies and services market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive healthcare technologies and services market.

Detailed Segmentation-

  • By Service Type:
    • Diagnostic Services
    • Wellness & Health Assessment Services
    • Telemedicine Services
    • Pharmacy Services
    • Others
  • By Technology Type:
    • Telemedicine
    • mHealth
    • Health Information Technology
    • Wearable Devices
    • Others
  • By End User:
    • Healthcare Providers
    • Healthcare Payers
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Healthlane
    • Abbott
    • GSK plc
    • Myriad Genetics
    • Omron Healthcare Inc.
    • Quest Diagnostics
    • Pfizer, Inc.
    • Merck & Co., Inc.
    • Omnicell
    • Novx Systems, Corp.
    • U-Systems, Ltd.
    • Viatronix, Inc.
    • Scripto LLC
    • Lifecom, Inc.
    • Dilon Medical Technologies, Inc.
    • McKesson Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By Technology Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Brand and Pricing Analysis
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Preventive Healthcare Technologies And Services Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Preventive Healthcare Technologies And Services Market, By Service Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Diagnostic Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Wellness & Health Assessment Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Telemedicine Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pharmacy Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Preventive Healthcare Technologies And Services Market, By Technology Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Telemedicine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • mHealth
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Health Information Technology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Wearable Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Preventive Healthcare Technologies And Services Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Healthcare Providers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Healthcare Payers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Preventive Healthcare Technologies And Services Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Healthlane
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott
    • GSK plc
    • Myriad Genetics
    • Omron Healthcare Inc.
    • Quest Diagnostics
    • Pfizer, Inc.
    • Merck & Co., Inc.
    • Omnicell
    • Novx Systems, Corp.
    • U-Systems, Ltd.
    • Viatronix, Inc.
    • Scripto LLC
    • Lifecom, Inc.
    • Dilon Medical Technologies, Inc.
    • McKesson Corporation

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact